These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13831078)

  • 41. A new influenza A virus infection in turkeys. VII. Comparative immunology.
    Rouse BT; Lang G; Narayan O
    Can J Comp Med; 1971 Jan; 35(1):44-51. PubMed ID: 4251414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A ge distribution of antibodies to animal influenza A viruses in human sera.
    Gorbunova AS; Pysina TV
    Bull World Health Organ; 1968; 39(2):271-5. PubMed ID: 5303408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [L-antigen in influenza virus strains of different age and grade of adaptation].
    BRAND G; SCHMIDT B
    Zentralbl Bakteriol; 1960 Jan; 177():20-5. PubMed ID: 13849155
    [No Abstract]   [Full Text] [Related]  

  • 45. [Analysis of interactions between influenza virus and murine serum proteins in non-infected and infected mice].
    Meringova LF; Iakovleva IV; Kramskaia TA
    Vestn Akad Med Nauk SSSR; 1991; (4):44-7. PubMed ID: 1866987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine.
    Cox F; Saeland E; Baart M; Koldijk M; Tolboom J; Dekking L; Koudstaal W; Lövgren Bengtsson K; Goudsmit J; Radošević K
    Virol J; 2015 Dec; 12():210. PubMed ID: 26643820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Qualitative heterogenicity of the antigen properties of the virus of type B influenza isolated at various times].
    KOSIAKOV PN; ROVNOVA ZI
    Vopr Virusol; 1960; 5():725-31. PubMed ID: 13753344
    [No Abstract]   [Full Text] [Related]  

  • 48. [Morphological properties of 3 types of influenza virus, including 1 with double antigen].
    PORTOCALE R; DUMITRESCO S; IONESCU I; BRONITKI A
    Vopr Virusol; 1961; 6():408-15. PubMed ID: 14488143
    [No Abstract]   [Full Text] [Related]  

  • 49. [Antigenic properties of influenza virus B isolated in 1950].
    IL'INA Ts
    Vopr Virusol; 1956; 1(1):39-41. PubMed ID: 13352962
    [No Abstract]   [Full Text] [Related]  

  • 50. [Materials on the study of antigenic structure and some biological properties of strains of an influenza virus of A2 type isolated in 1965].
    Iatel' TP
    Mikrobiol Zh; 1967; 29(3):236-42. PubMed ID: 5618090
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antigenic differences between horse serum-sensitive and insensitive influenza A2 substrains from the same isolate].
    Frösner GG; Gerth HJ
    Arch Gesamte Virusforsch; 1972; 36(3):317-23. PubMed ID: 4112024
    [No Abstract]   [Full Text] [Related]  

  • 52. Intracellular proteins associated with the synthesis of the influenza A virus.
    HENDERSON JR; KEMP F JE
    Virology; 1959 Sep; 9():72-83. PubMed ID: 14400989
    [No Abstract]   [Full Text] [Related]  

  • 53. Study of the neutralizing activity of immune sera to various types of influenza virus and Sendai parainfluenza virus.
    YABROV AA
    Probl Virol; 1961; 6():198-202. PubMed ID: 14040350
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on the content of antibodies for equine influenza viruses in human sera.
    Masurel N; Mulder J
    Bull World Health Organ; 1966; 34(6):885-93. PubMed ID: 5296537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gross physical properties of emulsified influenza virus vaccines and the adjuvant response.
    BERLIN BS
    J Immunol; 1960 Jul; 85():81-9. PubMed ID: 13799542
    [No Abstract]   [Full Text] [Related]  

  • 56. [On hemagglutination and antibody content determinations. V. Studies on the reaction between virus and antibodies specifically inhibiting hemagglutination with influenza virus strains].
    DRESCHER J
    Zentralbl Bakteriol; 1959 Aug; 175():485-504. PubMed ID: 13849643
    [No Abstract]   [Full Text] [Related]  

  • 57. Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.
    Di Mario G; Sciaraffia E; Facchini M; Gubinelli F; Soprana E; Panigada M; Bernasconi V; Garulli B; Siccardi A; Donatelli I; Castrucci MR
    Pathog Glob Health; 2017 Mar; 111(2):76-82. PubMed ID: 28079473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [On vaccinal strains of influenza viruses].
    RITOVA VV; EVSTIGNEEVA NA
    Vopr Virusol; 1960; 5():172-8. PubMed ID: 14437613
    [No Abstract]   [Full Text] [Related]  

  • 59. Serological characteristics of a "new" serotype of influenza A virus: the Hong Kong strain.
    Masurel N
    Bull World Health Organ; 1969; 41(3):461-8. PubMed ID: 5309456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Action of a bacterial mucinase on inhibitors of hemagglutination by influenza virus].
    BERGAMINI L; BARTOLOMEI-CORSI O
    Sperimentale; 1956; 106(1):76-87. PubMed ID: 13351967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.